Retatrutide 15mg

Purchase Retatrutide 15mg – High-Purity Research Peptide

Retatrutide is a next-generation investigational peptide that functions as a triple receptor agonist, targeting GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors. This multi-pathway approach is currently being studied for its potential to deliver more effective outcomes in metabolic regulation, weight loss, and glycemic control than traditional single-pathway agents.

Each vial of Retatrutide 15mg is synthesized to a purity level of ≥98% and undergoes rigorous analytical testing, including HPLC and mass spectrometry. This ensures maximum reliability and consistency for use in scientific research settings. The peptide is supplied as a lyophilized powder, ideal for long-term storage and easy reconstitution under sterile conditions.

Key Features:

• Concentration: 15mg per vial

• Purity: ≥98% (HPLC verified)

• Form: Lyophilized powder

• Molecular Weight: ~4,940 Da

• Storage: Store at -20°C for long-term stability; protect from moisture and light

• Applications: Preclinical and in vitro research focused on obesity, type 2 diabetes, appetite regulation, and energy balance

Research Use Only:

 As a triagonist peptide, its ability to activate multiple receptors may offer synergistic effects, making it a compelling candidate for future therapeutic development.

 It should only be handled by qualified professionals in a controlled laboratory setting.